Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.7.3299

Identification of Homer1 as a Potential Prognostic Marker for Intrahepatic Cholangiocarcinoma  

Wu, San-Yun (Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University)
Yu, Ming-Xia (Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University)
Li, Xiao-Gai (Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University)
Xu, Shu-Fang (Department of Intensive Care Unit, Central Hospital of Wuhan)
Shen, Ji (Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University)
Sun, Zhen (Department of Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors Hubei Cancer Clinical Study Center)
Zhou, Xin (Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University)
Chen, Xing-Zhen (Department of Physiology, University of Alberta)
Tu, Jian-Cheng (Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.7, 2014 , pp. 3299-3304 More about this Journal
Abstract
Background: The aim of the present study was to analyze whether Homer1 is a potential prognostic marker for intrahepatic cholangiocarcinoma (ICC). Materials and Methods: The expression of Homer1 in ICC tissue was detected with immunohistochemistry and levels of protein in ICC and paratumor tissues were evaluated by Western blotting. Survival analysis by the Kaplan-Meier method was performed to assess prognostic significance. Results: Homer1 expression was high in 67.4% (58/86) of ICC samples, and there was significant difference between ICC and adjacent noncancerous tissues (p<0.001); high expression was associated with poor histologic differentiation (p=0.019), TNM stage (p=0.014), lymph node metastasis (p=0.040), and lymphatic invasion (p=0.025). On Kaplan-Meier analysis, a comparison of survival curves of low versus high expressors of Homer1 revealed a highly significant difference in OS (p=0.001) and DFS (p=0.006), indicating that high expression of Homer1 was linked with a worse prognosis. Multivariate analyses showed that Homer1 expression was an independent risk factor predicting overall survival[Hazard ratio(HR), 7.52; 95% confidence interval (CI), 2.63-21.47; p=0.002] and disease-free survival (HR, 11.56; 95%CI, 5.17-25.96; p<0.001) in ICC. Conclusions: Homer1 promotes lymphatic invasion and associates with lymph node metastasis and poor prognosis of ICC. The current study shows that Homer1 may be an independent prognostic factor for ICC patients after curative resection, and it provides an important basis for screening/treating high-risk patients.
Keywords
Intrahepatic cholangiocarcinoma; Homer1; prognosis; survival;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Nagata S (1999). Fas ligand-induced apoptosis. Annu Rev Genet, 33, 29-55.   DOI   ScienceOn
2 Wang S, El-Deiry WS ( 2003). TRAIL and apoptosis induction by TNF-family death receptors. Oncogene, 22, 8628-33.   DOI   ScienceOn
3 Xiao B, Tu JC, Petralia RS, et al (1998). Homer regulates the association of group I metabotropic glutamate receptors with multivalent complexes of Homer-related, synapt proteins. Neuron, 21, 707-16.   DOI   ScienceOn
4 Yin H, Lu C, Tang Y, Wang H, et al (2013). Enhanced expression of EphrinB1 is associated with lymph node metastasis and poor prognosis in breast cancer. Cancer Biomark, 13, 261-7.   DOI
5 Li Y, Cui J, Zhang CH, et al (2013). High-expression of DJ-1 and loss of PTEN associated with tumor metastasis and correlated with poor prognosis of gastric carcinoma. Int J Med Sci, 10, 1689-97.   DOI
6 Li Z, Qiu HY, Jiao Y, et al (2013). Growth and differentiation effects of Homer3 on a leukemia cell line. Asian Pac J Cancer Prev, 14, 2525-8.   과학기술학회마을   DOI
7 Patel T (2002). Worldwide trends in mortality from biliary tract malignancies. BMC Cancer, 2, 10.   DOI
8 Salanova M, Volpe P, Blottner D (2013). Homer protein family regulation in skeletal muscle and neuromuscular adaptation. IUBMB Life, 65, 769-76.   DOI
9 Sandona D, Tibaldo E, Volpe P (2000). Evidence for the presence of two homer 1 transcripts in skeletal and cardiac muscles. Biochem Biophys Res Commun, 279, 348-53.   DOI
10 Senol EP, Tasdelen I, Adim SB, et al (2013). A comparison of Ki 67 proliferative index in primary tumor and axillary metastatic lymph nodes with length of survival in patients with breast cancer. Bratisl Lek Listy, 114, 645-9.
11 Shin JN, Piya S, Yun CW, et al (2009). Homer1 regulates the susceptibility to TRAIL. Exp Cell Res, 315, 2249-55.   DOI
12 Soloviev MM, Ciruela F, Chan WY, et al (2000) Mouse brain and muscle tissues constit utively express high levels of Homer proteins. Eur J Biochem, 267, 634-9.   DOI
13 Suh I, Shibru D, Eisenhofer G, et al (2009). Candidate Genes Associated With Malignant Pheochromocytomas by Genome-Wide Expression Profiling. Ann Surg, 250, 983-90   DOI
14 Kawarada Y, Yamagiwa K, Das BC (2002). Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg, 183, 679-85.   DOI   ScienceOn
15 Bodmer JL, Holler N, Reynard S, et al (2002). TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol, 2, 241-3.
16 Brakeman PR, Lanahan AA, O'Brien R, et al (1997), Homer: a protein that selectively binds metabotropic glutamate receptors. Nature, 386, 284-8.   DOI   ScienceOn
17 Khan SA, Taylor-Robinson SD, Toledano MB, et al (2002). Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol, 37, 806-13.   DOI   ScienceOn
18 Khan SA, Thomas HC, Davidson BR, et al (2005). Cholangiocarcinoma. Lancet, 366, 1303-14.   DOI   ScienceOn
19 Kim Y, Seol DW (2003). TRAIL, a mighty apoptosis inducer. Mol Cells, 15, 283-93.
20 Kischkel FC, Lawrence DA, Chuntharapai A, et al (2000). Apo2L/TRA IL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity, 12, 611-20.   DOI   ScienceOn
21 Kuang AA, Diehl GE, Zhang J, et al (2000). FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. J Biol Chem, 275, 25065-8.   DOI   ScienceOn
22 LeBlanc HN, Ashkenazi A (2003). Apo2L/TRAIL and its death and decoy receptors, Cell Death Differ, 10, 66-75.   DOI   ScienceOn
23 LeBlanc HN, Lawrence D, Varfolomeev E, et al (2002). Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med, 8, 274-81.   DOI   ScienceOn
24 Anderson CD, Pinson CW, Berlin J, et al (2004). Diagnosis and treatment of cholangiocarcinoma. Oncologist, 9, 43-57.
25 Shaib YH, El-Serag HB, Nooka AK, et al (2007). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol, 102, 1016-21.   DOI   ScienceOn
26 Deng Y, Lin Y, Wu X (2002). TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIA BLO. Genes Dev, 16, 33-45.   DOI   ScienceOn
27 Alpini G, McGill JM, Larusso NF (2002). The pathobiology of biliary epithelia. Hepatology, 35, 1256-68.   DOI   ScienceOn